Malaria News and Research

Latest Malaria News and Research

ALMA receives ExxonMobil $250,000 grant to combat malaria

The African Leaders Malaria Alliance, an alliance of 39 African leaders, announced today that it has been awarded a $250,000 grant from the ExxonMobil Foundation to help with its campaign to combat malaria.

16 Mar 2011

OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology

OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.

15 Mar 2011

Global chronic disease burdens are increasing rapidly: Research

Those working for healthier humans around the globe are making headway in fighting communicable diseases such as AIDS, malaria and diarrheal illness, according to research from the Frederick S. Pardee Center for International Futures in the University of Denver's Josef Korbel School of International Studies.

15 Mar 2011

New findings may open doors for vaccine development against HIV, tuberculosis

Alum is an adjuvant used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine.

15 Mar 2011

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB, has initiated a Phase IIb clinical study of its ChronVac-C DNA vaccine for hepatitis C virus, delivered by Inovio's proprietary electroporation DNA vaccine delivery technology, in combination with standard of care.

14 Mar 2011

CHF signs agreement with Global Fund to implement HIV/AIDS program in Colombia

CHF International, the Silver Spring-MD based international development and humanitarian assistance organization, announced it signed an agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to implement a two-year HIV and AIDS program in Colombia, with the possibility to extend it for another three years.

11 Mar 2011

Canadian House of Commons passes bill that could ease access to generic drugs in developing countries

Canadian lawmakers in the country's House of Commons on Wednesday "approved a bill aiming to ease the process that lets generic drug manufacturers produce patented medicines for export to poor nations at cheaper prices in a move the pharmaceutical industry says could undermine intellectual property rights," Bloomberg reports.

11 Mar 2011

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

California Institute of Technology graduate student Guoan Zheng is the recipient of the 2011 $30,000 Lemelson-MIT Caltech Student Prize.

10 Mar 2011

House Foreign Affairs Committee hears testimony on security, human rights, health in Democratic Republic of Congo

At a House Committee on Foreign Affairs hearing on Tuesday, Ben Affleck, the actor, writer and director, and "other witnesses urged the Obama administration to immediately appoint a special envoy" for the Democratic Republic of Congo, which is due for a national election in November, CNN reports.

10 Mar 2011

Study supports DNA mismatch repair test for bowel cancer

Bowel cancer patients whose tumors contain defects in specific DNA repair systems are much less likely to experience tumour recurrence post surgery, results from a major clinical study have demonstrated.

9 Mar 2011

Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines

Human Rights Abuses Impacting Health Situation In Parts Of Myanmar, Study Says.

9 Mar 2011

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.

9 Mar 2011

ITMNs can reduce Japanese Encephalitis transmission to humans

A new study revealed that using treated mosquito nets could drastically reduce the transmission of Japanese Encephalitis to humans.

9 Mar 2011

Belly laugh best for venous leg ulcers

Forget technology. The best prescription for patients with venous leg ulcers is good quality nursing care - and the occasional belly laugh!

9 Mar 2011

Chemotherapy drugs also kill malaria parasite

A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.

9 Mar 2011

New insight into malaria

A group of researchers from EPFL's Global Health Institute and Inserm has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.

8 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.

7 Mar 2011

Recent releases in Global Health

The Importance Of Investing In Adolescent Girls: A Lancet editorial examines the challenges adolescent girls living in developing countries face and the work of the U.N. Adolescent Girls Task Force to help young women overcome these barriers.

5 Mar 2011

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.

5 Mar 2011

Malaria News and Research

Latest Malaria News and Research

ALMA receives ExxonMobil $250,000 grant to combat malaria

OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology

Global chronic disease burdens are increasing rapidly: Research

New findings may open doors for vaccine development against HIV, tuberculosis

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

CHF signs agreement with Global Fund to implement HIV/AIDS program in Colombia

Canadian House of Commons passes bill that could ease access to generic drugs in developing countries

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

House Foreign Affairs Committee hears testimony on security, human rights, health in Democratic Republic of Congo

Study supports DNA mismatch repair test for bowel cancer

Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

ITMNs can reduce Japanese Encephalitis transmission to humans

Belly laugh best for venous leg ulcers

Chemotherapy drugs also kill malaria parasite

New insight into malaria

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Recent releases in Global Health

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in